GB9307013D0 - Therapeutic combinations - Google Patents

Therapeutic combinations

Info

Publication number
GB9307013D0
GB9307013D0 GB939307013A GB9307013A GB9307013D0 GB 9307013 D0 GB9307013 D0 GB 9307013D0 GB 939307013 A GB939307013 A GB 939307013A GB 9307013 A GB9307013 A GB 9307013A GB 9307013 D0 GB9307013 D0 GB 9307013D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic combinations
therapeutic
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939307013A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB939307013A priority Critical patent/GB9307013D0/en
Priority to DE69326548T priority patent/DE69326548T2/en
Publication of GB9307013D0 publication Critical patent/GB9307013D0/en
Priority to JP6524894A priority patent/JPH07109221A/en
Priority to US08/825,674 priority patent/US6177435B1/en
Pending legal-status Critical Current

Links

GB939307013A 1992-05-13 1993-04-02 Therapeutic combinations Pending GB9307013D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB939307013A GB9307013D0 (en) 1993-04-02 1993-04-02 Therapeutic combinations
DE69326548T DE69326548T2 (en) 1992-05-13 1993-05-13 THERAPEUTIC COMBINATIONS
JP6524894A JPH07109221A (en) 1993-04-02 1994-04-01 Remedial combination
US08/825,674 US6177435B1 (en) 1992-05-13 1997-03-20 Therapeutic combinations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939307013A GB9307013D0 (en) 1993-04-02 1993-04-02 Therapeutic combinations

Publications (1)

Publication Number Publication Date
GB9307013D0 true GB9307013D0 (en) 1993-05-26

Family

ID=10733319

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939307013A Pending GB9307013D0 (en) 1992-05-13 1993-04-02 Therapeutic combinations

Country Status (2)

Country Link
JP (1) JPH07109221A (en)
GB (1) GB9307013D0 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6069252A (en) * 1990-02-01 2000-05-30 Emory University Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
US5914331A (en) * 1990-02-01 1999-06-22 Emory University Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US6391859B1 (en) 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
ATE230267T1 (en) * 1996-06-25 2003-01-15 Glaxo Group Ltd COMPOSITIONS CONTAINING VX478, ZIDOVUDINE AND 159U89 FOR USE IN THE TREATMENT OF HIV
NZ333099A (en) * 1996-06-25 2000-06-23 Glaxo Group Ltd synergistic combinations comprising 141W94, zidovudine and 3TC for use in the treatment of HIV
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions

Also Published As

Publication number Publication date
JPH07109221A (en) 1995-04-25

Similar Documents

Publication Publication Date Title
GB9300051D0 (en) Therapeutic agents
GB9312891D0 (en) Therapeutic agents
GB9312893D0 (en) Therapeutic agents
GB9309573D0 (en) Therapeutic agents
GB9312806D0 (en) Therapeutic agents
GB9307013D0 (en) Therapeutic combinations
GB9305644D0 (en) Therapeutic agents
GB9317146D0 (en) Therapeutic combinations
GB9308962D0 (en) Therapeutic agetns
GB9306646D0 (en) Therapeutic agetns
GB9323437D0 (en) Therapy
GB9216088D0 (en) Therapeutic combinations
GB9210270D0 (en) Therapeutic combinations
GB9210256D0 (en) Therapeutic combinations
GB9305642D0 (en) Therapeutic agents
GB9307318D0 (en) Therapeutic agents
GB9304111D0 (en) Therapeutic agents
GB9304398D0 (en) Therapeutic agents
GB9304524D0 (en) Therapeutic agents
GB9304525D0 (en) Therapeutic agents
GB9305373D0 (en) Therapeutic agents
GB9305619D0 (en) Therapeutic agents
GB9305628D0 (en) Therapeutic agents
GB9304063D0 (en) Therapeutic agents
GB9305643D0 (en) Therapeutic agents